Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · IEX Real-Time Price · USD
13.45
+0.38 (2.91%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Enanta Pharmaceuticals Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for ENTA stock have an average target of 19, with a low estimate of 11 and a high estimate of 27. The average target predicts an increase of 41.26% from the current stock price of 13.45.
Analyst Consensus: Hold
* Price targets were last updated on May 7, 2024.
Analyst Ratings
The average analyst rating for ENTA stock from 6 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 4 | 4 | 4 | 3 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $28 → $27 | Strong Buy | Maintains | $28 → $27 | +100.74% | May 7, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $23 → $22 | Buy | Maintains | $23 → $22 | +63.57% | May 7, 2024 |
| JP Morgan | JP Morgan | Sell Maintains $12 → $11 | Sell | Maintains | $12 → $11 | -18.22% | Feb 8, 2024 |
| Oppenheimer | Oppenheimer | Hold Maintains $25 → $21 | Hold | Maintains | $25 → $21 | +56.13% | Nov 22, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $28 | Strong Buy | Maintains | $30 → $28 | +108.18% | Nov 21, 2023 |
Financial Forecast
Revenue This Year
70.48M
from 79.20M
Decreased by -11.01%
Revenue Next Year
75.51M
from 70.48M
Increased by 7.14%
EPS This Year
-5.91
from -6.38
EPS Next Year
-5.38
from -5.91
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 75.1M | 117.5M | 114.7M | 240.0M | 399.1M |
| Avg | 70.5M | 75.5M | 73.3M | 109.2M | 160.9M |
| Low | 66.2M | 61.7M | 31.4M | 54.9M | 59.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -5.2% | 66.8% | 51.9% | 227.4% | 265.5% |
| Avg | -11.0% | 7.1% | -2.9% | 48.9% | 47.3% |
| Low | -16.4% | -12.4% | -58.5% | -25.2% | -45.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -5.39 | -4.91 | -2.93 | -1.63 | -6.78 |
| Avg | -5.91 | -5.38 | -5.02 | -4.37 | -6.59 |
| Low | -6.17 | -6.02 | -7.82 | -6.88 | -6.33 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.